Although the neurotoxicity of aluminum is well established, the association between the metal and dementia or associated disorders remains a subject of debate. In this article, we present a review of articles published on epidemiologic studies of this subject. Different sources of exposure are considered (occupational exposure, aluminum-containing products), with emphasis on drinking water. We separate the various health effects of aluminum into three categories: neurological disorders (other than cognitive decline or AD); cognitive decline; and dementia or Alzheimer's disease. Furthermore, we present the results obtained on silicon in drinking water, a chemical constituent that interacts with aluminum. We conclude that not enough epidemiological evidence supports a link between aluminum in drinking water and AD. The role of silica in drinking water has been less studied, and clear results have not yet emerged.
INTRODUCTION
Alzheimer's disease (AD), the most common cause of senile dementia, is a progressive brain disorder that affects memory and other cognitive functions. Alzheimer's disease is characterized by a number of important pathological changes. A loss of neurons and synapses occurs in many areas of the central nervous system. Abnormalities in the processing of the amyloid precursor protein are considered central to the pathogenesis of AD, initiating a pathological 'cascade' leading to the development of senile plaques and neurofibrillary tangles, cell death, and dementia.
Although much effort has been devoted to identifying the genetic determinants of AD /l/, it is likely that certain environmental factors play a role in this disease. Because of its proven neurotoxicity, aluminum (Al) may be one such factor. Several biological findings support the hypothesis of a link between Al and AD 12-51, but uncertainty still prevails. The involvement of Al as a risk factor for AD is suggested by its presence in several sources. Several studies (reviewed in /6/) reported that Al is found in senile plaques and neurofibrillary tangles, the principal pathological features of AD. The results of those studies were refuted 111, however, because the presence of the metal was attributed to the contamination of the tissue samples by Al from fixatives and staining reagents.
Aluminum enters the environment as a major constituent of atmospheric particulates originating from natural soil erosion, mining or agricultural activity, volcanic eruptions, or coal combustion. The concentration of aluminum in natural waters can vary, depending on various physicochemical and mineralogical factors. Aluminum levels in drinking-water vary according to the levels found in the source water and whether Al coagulants are used during water treatment.
The identification of Al as the causal agent of dialysis encephalopathy /8/, a fatal brain disorder once prevalent in patients on long-term hemodialysis, was one of the main clues in favor of the neurotoxicity of the metal because it proved that Al can enter the brain and can induce neurofibrillary degeneration and neuronal death. To a limited but as yet undetermined extent, aluminum passes the blood-brain barrier (BBB) that separates the blood from the cerebral interstitial fluid 191. Furthermore, human 26 A1 tracer studies, as well as observations in humans and experimental animals, have shown that the metal is absorbed /10/ and can enter the central nervous system, depending on the route of administration and chemical form of Al. Now more and more studies are showing that analyses of a possible relation between Al in drinking water and the risk of AD or cognitive impairment must be made after adjusting for other water constituents that could play a confounding role by masking the neurotoxicity of ingested Al. In particular, the confounding effect of silicon in tap water has been studied. Birchall et al. /11/ showed that silicon reduces the toxicity of Al in fish because hydroxylmaluminosilicate compounds prevent the absorption of Al. The results of Edwardson et al. /12/ confirmed this conclusion in a study of five healthy men, showing that the gastrointestinal absorption of Al administered in orange juice is reduced if sodium silicate is added to the beverage.
From these studies, two hypotheses have been proposed. The first was suggested by Birchall and Chappell /13/, who pointed out that generally, Al and silicon concentrations in drinking water are negatively correlated, confirming that silicon may be a confounding factor in the reported statistical association between Al in drinking water and AD. Taylor et al. /14/ showed a significant inverse correlation between soluble silicon and soluble Al (r = -0.43, ρ <0.001). Moreover, silicon from drinking water could be an important part of the daily silicon intake and in a form that is particularly available for association with Al.
As a second hypothesis, Birchall and Chapel I /13/ suggested that the low association between Al levels in drinking water and AD might be a consequence of the protective effect of silicon in the water. Silicon in water might protect populations not only from Al in water but also from the effect of dietary Al intake. More specifically, Exley and Birchall/15/ suggested that a concentration of silicic acid, produced when sodium silicate solution is acidified, of >100 μιηοΙ/L might prevent the absorption of Al from the gastrointestinal tract and facilitate its excretion by the kidney. The literature on this topic is abundant, and several reviews exposing both positive and negative associations between Al and AD have already been published /16-18/. In the present paper, we review the epidemiologic studies that have been conducted until now by distinguishing the different health effects of Al or silica with regard to neurological disorders (other than cognitive decline and AD), cognitive decline, and dementia or Alzheimer's disease. For each health effect, we tried to separate the different sources of Al exposure: water, occupational, Al-containing products (like drugs or antiperspirants), and other sources of exposure.
NEUROLOGICAL DISORDERS OTH ER THAN COGNITIVE DECLINE OR AD

Water Exposure
Dialysis encephalopathy is not AD but rather a 'model', in that when a large quantity of Al enters the blood from water, then at least a part of it can cross the BBB and cause lesions having certain similarities to those of AD /8, 18/. Several studies /19, 20/ have strongly implicated the municipal tap waters containing high concentrations of Al that were used to prepare the dialysates. Since the discovery that Al from the dialysate can cause encephalopathy, the exposure of such patients to the element has been greatly reduced, with the result that dialysis encephalopathy has become relatively rare. Perazella and Brown /21/ described a patient with renal failure who developed an acute encephalopathy after bone marrow transplantation from apparent Al intoxication following intravesical AL instillation for hemorrhagic cystitis. Nakamura et al. 1221 reported the successful treatment with deferoxamine in a patient who developed acute encephalopathy during dialysis. The symptoms associated with acute Al toxicity appear to be reversible with deferoxamine, which is recognized as an effective chelator of Al /23/.
Al-Containing Products
Alfrey et al. /8/ measured Al levels in bone, muscle, and brain in 10 control subjects, 9 uremic dialysis patients, and 12 uremic hemodialysis patients with the encephalopathy syndrome. All dialyzed patients had received oral Al-hydroxide gels to control phosphate levels. High levels of Al were found in the tissues and particularly in the gray matter of the brain in patients dying from this syndrome. The Al content of the gray matter was 2.18 in controls, 6.50 (not significant) in the uremic group on dialysis, and 24.98 in the patients with encephalopathy (p<0.01 versus control; ρ < 0.01 versus uremic). In that study, the Al content of the water used for preparing the dialysate was repeatedly measured and found negligible. 
Occupational Exposure
Workers in refineries or smelters can be exposed to Al in the form of dusts, fumes, and/or skin contact. Benke et al. /25/ reviewed different specific chemical exposures and exposure assessment methods relating to epidemiologic studies in the Al industry. As Al dust had been shown to reach the central nervous system via the nasal olfactory pathway /26/, several epidemiologic studies were conducted to examine the potential relation between Al exposure in the workplace and the risk of neurological disorders. The idea of a neurotoxic effect of Al from occupational exposure began with a fatal case of encephalopathy associated with the inhalation of Al dust 1211.
Other Types of Exposure
A further link between Al and neurodegenerative disorders was found in areas of the Western Pacific, such as the island of Guam, which has unusual soils containing high amounts of Al and low amounts of magnesium and calcium. The inhabitants are particularly prone to amyotrophic lateral sclerosis or to Parkinsonism with dementia and, in either case, the brains of affected subjects show neurofibrillary tangles like those seen in AD /28/.
COGNITIVE FUNCTIONS
Water Exposure
A description of different epidemiologic studies on the relation between Al and cognitive functions is presented in Table 1 . Two studies, one from Britain (Wood et al. 1291 ) and the other from Switzerland (Wettstein et al. /30/), did not find a relation between impaired cognitive function and Al exposure in drinking water. Wettstein compared the degree of mental impairment in elderly residents (81 to 85 y) in two parts of a town having different levels of Al in their drinking water. The mean scores of tests (using two simple subtests of the variant Zurick Mini Mental Status Tests) in the low and in the high district were almost identical. Perhaps the failure to detect any relation was that only two drinking water sources were investigated, and the highest concentration of Al measured in these waters was about 0.1 mg/L. Perhaps other water components or other characteristics of the geographic area influenced any possible relation between Al and AD. Thus, it is important to include diverse geographic areas in epidemiological studies.
More recently a case-control study /31 / was undertaken in Camelford (South England) after an incident in 1988 that contaminated the water supplies with 20 tons of aluminum sulfate used in the treatment of drinking water. Three years after the incident, an investigation was conducted to examine 55 self-selected adults (30 females and 25 males, aged 15 to 70 y, mean 41.8 ± 2.1 y), who complained of short-term memory loss and impaired concentration. These subjects were compared with 15 siblings nearest in age to one of the group, but who had not been exposed to the contaminated water. The results showed that the psychomotor performances of the Camelford participants exposed to Al were lower than those of their controls. Nevertheless, several shortcomings in the design of the study must be pointed out. The inquiry examined only a small number of exposed and nonexposed subjects. Moreover, the population was self-selected, according to cognitive impairment and was certainly not representative of the local population. Thus, the results of psychomotor testing were probably influenced and biased by the participants who perceived themselves as victims of this incident. Nevertheless, the results found on the visual evoked potential test, which is an objective test, are probably resistant to bias caused by litigation.
A series of papers /32-34/ presented the results of the Ontario Longitudinal Study of Aging (LSA) whose participants were followed up for about 30 y to study the relation between dementia, Al, and fluoride. These studies reported, for example, an odds ratio of 2.72 (p < 0.01) for subjects in areas having relatively low fluoride concentrations in the drinking water (< 0.88 mg/L) and relatively high Al concentrations (> 0.085 mg/L), compared with subjects in areas where the fluoride concentrations were high and the Al concentrations low /33/.
The relation between Al, fluorine, calcium, and pH in drinking water and the risk for cognitive impairment was explored using data collected in a large population-based study (the Paquid cohort-QUID sur les Personnes Agees: QUID in the elderly) 1351. In one analysis of the Paquid sample, a weighted mean measure of exposure to Al was computed using results of two surveys conducted in 1991. A history of the water distribution network over the previous decade (1981 to 1991) was established to evaluate the past exposure of the subjects. The results of the Paquid cohort, including 3,777 subjects aged 65 y and over and living at home in 75 civil parishes in Southwestern France in 1988-1989, showed an association of baseline cognitive impairment (defined as a score of less than 24 on the Mini-Mental State Examination) with Al, pH, and calcium (negatively associated). Certain results were difficult to explain; Al was positively associated when the pH was < 7.3 but negatively associated when the pH was higher. Several investigators have reported that the pH of drinking water can affect the solubility of Al components and the type of Al-containing species that are formed. Plausibly, the bioavailability of Al is higher at low than at high pH, which could lead to an interaction between pH and Al. Forbes et al. /34/ found that at neutral pH, relatively low Al concentrations and relatively high fluoride concentrations decrease-by a factor of about 5-the odds of exhibiting cognitive impairment as compared with other types of drinking water.
More recently, we evaluated the association between Al in drinking water and the evolution of cognitive functions in the Paquid cohort /36/, measured by a major predictor of dementia, the Mini-Mental State Examination (MMSE) score. The analysis had two main methodological focuses: First, the evolution of the MMSE score is not sensitive to diagnostic errors that may be present in the detection of demented or Alzheimer's disease cases. Second, cognitive decline is believed to precede by 3 to 5 years the occurrence of dementia and is less subject to competitive morbidity or mortality. The analysis suggested that cognitive decline with time may be related to high concentrations (>0.1 mg/L) of Al or to low concentrations (< 11.25 mg/L) of silica in drinking water.
Occupational Exposure
Chronic exposure to Al and the possible neurotoxicity of Al were examined in a study of 607 Canadian gold miners exposed to Mclntyre Powder, a form of aluminum dust used as a prophylactic agent against silicosis /37/. The cognitive impairment of exposed miners was almost twice that of unexposed miners. The length of treatment ranged from 6 mo to 36 y, and the proportion of workers with impaired cognitive function increased progressively with the duration of treatment. This study, however, which had insufficient data for the control group over 65 y of age, could not conclude whether the increased absorption of Al was related to the process of dementia or was a consequence of aging. The data also showed that the urine silicon concentrations in the urine of the demented group were significantly different from those of the control group (respective mean μηιοΙ/L ± 1 s.d.: 1587 ± 645 and 471 ± 322). This observation suggests that increased silicon excretion in dementia might be associated with increased Al excretion, possibly by the formation of aluminosilicates.
Water exposure
A synthesis of the different epidemiologic studies on Al and dementia is presented in Table 2 and  Table 3 . Most epidemiologic studies focused on the association between Al in tap water and AD, despite this source of exposure representing a relatively minor proportion of intake when compared with other dietary and non-dietary sources. Less than 5% of the daily intake of Al has been reported to come from Al in public water supplies /42/. Nevertheless, data on Al in drinking water are relatively available, and it is widely thought that Al in drinking water is more bioavailable, namely, more readily taken up from the gut into the bloodstream, than Al in food. Furthermore, in individuals exposed to drinking water with a high concentration of Al, a much lower quantity of Al can cross the BBB, the effect of which could be simply to accelerate an Most studies were ecologic in design, in that they studied the relation between the rates of Two recent British studies failed to find any relation between AD and Al in drinking water /50, 51/. In a study by Forster /50/ of modest statistical power (109 cases vs. 109 controls), no association was found between presenile dementia of the Alzheimer type and the presence of Al in drinking water, related either to a person's main place of residence 10 y before dementia onset or to birthplace. Martyn et al. /51/ carried out a casecontrol study in which they assessed exposures from historical measurements of Al in water supplies. No tendency for an increased risk with Al concentration was found when Al levels were averaged from age 25 y to diagnosis, from age 25 y to 10 y before diagnosis, or over 10 y before diagnosis. The association was, in fact, the inverse. The inconsistency between these results and those of other studies may be explained not only by methodological problems (such as the number of subjects enrolled) but also by the above mentioned studies examining younger subjects (aged 43 to 75 y), meaning that the authors examined presenile dementia rather than senile dementia of the Alzheimer type.
The effect of Al in drinking water on the risk of AD was examined in the Paquid cohort (n = 3,777; described in Sec. 3.1). The first report of the results 1521 obtained on 40 prevalent cases of probable AD among a sub-sample of 2,792 subjects showed a significant linear association (RR = 4.53 (3.36-6.10), for a difference of 0.1 mg/L between the two values compared. This association, however, was based on retrospective measures of Al concentrations that were not reliable. In particular, certain measures were old, and sampling and measurement techniques have changed in recent decades. We recently published the results obtained on incident cases of AD after 8 y of follow-up /53/. In this study, additional results of chemical analyses of drinking water, carried out by the sanitary administration between 1991 and 1994, were used to evaluate Al exposure. The sample studied included 2,698 non-demented subjects at baseline, for whom components of drinking water and covariates were available. We identified a total of 253 incident cases of dementia (with 17 exposed to high levels of Al), including 182 AD (with 13 exposed to high Al levels). The RR of dementia adjusted for age, gender, educational level, place of residence; and wine consumption was 1.99 (95% CI 1.20-3.28) for subjects exposed to an Al concentration > 0.1 mg/L (a threshold already used in previous studies /43, 49/). A similar result was found specifically for AD (adjusted RR = 2.14, 95% CI 1.21-3.80). No dose-response relation was found, however.
The results of the same cohort study also showed that high silica levels (> 11.25 mg/L) are associated with a lower risk of dementia (adjusted RR = 0.74, 95% CI 0.58-0.96) and AD (adjusted RR = 0.73, 95% CI 0.55-0.99). The results are concordant with the hypothesis of Birchall and Chapell /13/ that failure to detect an association between Al levels in drinking water and AD might be due to a protective effect of silicon. If this assumption is true, then the exact risk attributable to Al is probably underestimated in the Paquid cohort, which does not consider total daily Al intake (difficult to measure). On the other hand, the results obtained by Martyn et al. /51/ in a case-control study do not support a protective role of silicon.
Gauthier et al. /54/ used a case-control study (68 cases) in Quebec to assess the relation between long-term exposure to dissolved Al forms and AD development, diagnosed using NINCDS-ADRDA criteria 1551. Potential individual long-term exposure to AI forms in drinking water was assessed by combining the subject's residential history (from 1945) with the physicochemical data of the municipalities. In contrast to earlier studies, this case-control study included information on genetic characteristics of the subjects and Al speciation in water (in addition to educational level Iron concentration is also of interest because transferrin is the major transport protein for both iron and Al in blood. Eighty percent of the Al reaching the blood combines with transferrin, forming high molecular weight complexes that prevent Al from entering the brain. Farrar et al. /56/ reported that in AD patients, the binding of an analogue of Al to transferrin is significantly reduced because Al and iron compete for the same binding sites on these molecules. The authors proposed that such patients might have higher plasma levels of unbound, low-molecular weight Al complexes, which could readily cross the BBB. In a multivariate analysis, Forbes et al. /57/ found a relation between the level of iron in tap water and the risk of AD reported on death certificates for persons over the age of 85 y.
Al-Containing Products
Aluminium hydroxide is widely used as an antacid to relieve gastric irritation. The regular ingestion of Al-containing antacids represents a major source of exposure to Al. Very few studies, however, have related the use of antacids to the development of AD. Two case-control studies have explored such an association /58, 50/. Forster et al. /50/ obtained an OR equal to 1.6 (95% CI 0.77-3.51) for prolonged (6 mo) antacid users, but this association was not significant. The results of Graves and colleagues /58/ were surprising: when all antacids were considered in a case-control study of 130 matched pairs, the adjusted OR for AD was 3.1 (95% CI 1.3-7.5), with a dose-response gradient. Yet, when only Al-containing antacids were analyzed, the overall adjusted OR was only 0.7 (95% CI 0.3-2.0). The data from a long-term mortality follow-up study of 9,928 patients 1591 did not indicate that these individuals, who presumably ingested large amounts of antacids containing Al, were at greater risk of AD.
Aluminum salt is the major constituent of many widely used antiperspirant products. Aluminum chloride was the first compound used but aluminum chlorohydrate is currently the major antiperspirant compound. The possibility that antiperspirant Al might exert an effect on health should not be ignored /60/. Experimental animal studies on mice have shown that aluminum salt can pass through the skin barrier, and that the transdermal uptake of Al results in an accumulation of Al in the hippocampus of the brain /61/. In the field of epidemiology, however, little consideration has been given to the effect of using antiperspirants with regard to Al and the risk of AD. To our knowledge, only one epidemiologic study has revealed an increased risk of AD for subjects using ΑΙ-containing antiperspirants, with a trend toward a higher risk with increasing frequency of use /58/.
Aluminum is present in food naturally or from the use of aluminum-containing food additives. Epidemiological studies on Al exposure from food are uncommon, probably due to the difficulties of measuring such exposure. In a recent preliminary case-control study (23 AD cases versus 23 controls matched by age, gender and date of admission to the center), Rogers and Simon /62/ examined the association between the consumption of food containing Al additives and risk of Alzheimer's disease. Next-of-kin for patients with AD and controls completed an interview on the subject's medical history, lifestyle habits, and dietary history (using the Health Habits and History Questionnaire), so that the use of Al-containing food could be ascertained over the 5-y period preceding the diagnosis for cases and over the same number of years for controls. Consuming food with a high Al content, at least once per day, yielded a crude OR of 2.0 and an adjusted OR of 8.6, but this association was not significant (p = 0.19). No clear association was found with the consumption of tea, although tea infusions are a potential important source of dietary Al. In a case-control study, Forster et al. /50/ found an elevated OR (OR = 1.4, 95% CI 0.81-2.63) with tea consumption (>4cups/d), but this association was not significant.
Occupational Exposure
No evidence has been presented that long-term Al exposure in the workplace leads to dementia and AD. Three recent case-control studies found no association between workers in contact with Al dust and fumes, and AD /63-65/. The lack of consistency in the data from these reports may be due to differences in exposure assessment. Namely, subjects are often exposed to several potential toxicants other than Al, making difficult the identification of the role of Al in the occupational environment. Furthermore, most studies were based on a small number of subjects.
Other Types of Exposure
Significant amounts of Al may also be supplied by aluminum cooking utensils, although such exposure has attracted less attention than other sources. The bioavailability of Al in cookware is unclear, despite the knowledge that such utensils may release Al when used to cook acidic food /66-68/. Aluminum might be more bioavailable when dissolved in water than in foodstuffs. In a prospective study /53/, the use of Al cookware had no influence on the risk of dementia (RR = 1.04, ρ = 0.86).
CONCLUSION AND PERSPECTIVES
The most solid evidence favoring the neurotoxicity of Al is that obtained from cases of dialysis encephalopathy, for which Al might be a causal agent. Nevertheless, the link between Al in drinking water and either cognitive impairment or AD remains controversial, with a mixture of positive and negative epidemiologic results. The role of silica in drinking water has been less studied from an epidemiologic point of view, and clear results have not yet emerged. 
